Profile data is unavailable for this security.
About the company
CK Life Sciences Intl (Holdings) Inc is an investment holding company principally engaged in the development and sales of healthcare products. The Company operates through two segments. The Health segment is engaged in the development, production, marketing and sales of healthcare and pharmaceutical products. The healthcare brands under the Company include Lipa, Vitaquest and Sante Naturelle, among others. Its pharmaceutical products include cancer-related pharmaceuticals and painkillers, among others. The Agriculture-related Businesses segment is engaged in the operation of vineyards, as well as the development, production, marketing and sales of agriculture and related products. Its agricultural products include fertilizers and crop protection products, among others.
- Revenue in HKD (TTM)5.32bn
- Net income in HKD17.25m
- Incorporated--
- Employees1.93k
- LocationCK Life Sciences Intl (Holdings) Inc2 Dai Fu StreetTai Po Industrial Estate Hong KongHKG
- Phone+852 21261212
- Fax+852 21261211
- Websitehttps://www.ck-lifesciences.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Frontage Holdings Corp | 2.03bn | 84.35m | 2.59bn | 1.76k | 31.11 | 0.9663 | 7.15 | 1.27 | 0.0408 | 0.0408 | 0.9799 | 1.31 | 0.463 | 60.63 | 5.32 | 1,152,935.00 | 1.91 | 4.46 | 2.33 | 5.28 | 30.17 | 34.00 | 4.13 | 9.92 | 1.39 | 4.09 | 0.296 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
| MicroPort CardioFlow Medtech Corp | 362.55m | -508.46m | 2.75bn | 592.00 | -- | 1.09 | -- | 7.59 | -0.2152 | -0.2152 | 0.1534 | 1.04 | 0.1205 | 2.78 | 3.67 | 612,407.30 | -16.91 | -17.37 | -18.11 | -22.96 | 2.06 | -1.67 | -140.25 | -180.82 | 9.91 | -11.56 | 0.0293 | -- | 33.94 | -- | -3.77 | -- | -14.16 | -- |
| Laekna Inc | 0.00 | -397.70m | 2.78bn | 89.00 | -- | 3.20 | -- | -- | -3.30 | -3.30 | 0.00 | 2.22 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -5.28 | 0.0655 | -- | -- | -- | 52.81 | -- | -- | -- |
| Golden Throat Holdings Group Co Ltd | 1.04bn | 269.75m | 2.80bn | 869.00 | 10.39 | 1.68 | 8.99 | 2.70 | 0.3649 | 0.3649 | 1.40 | 2.26 | 0.4181 | 4.82 | 1.85 | 1,192,941.00 | 10.88 | 11.00 | 15.85 | 15.63 | 72.57 | 72.79 | 26.02 | 24.67 | 2.48 | 34.74 | 0.21 | 83.15 | -3.09 | 6.73 | -11.04 | 19.61 | -32.13 | 38.94 |
| HighTide Therapeutics Inc | 0.00 | -1.01bn | 3.13bn | 66.00 | -- | 3.79 | -- | -- | -2.14 | -2.14 | 0.00 | 1.60 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0229 | -- | -- | -- | -393.76 | -- | -- | -- |
| China Isotope & Radiation Corp | 7.15bn | 400.02m | 3.60bn | 3.11k | 9.00 | 0.7117 | 3.33 | 0.5034 | 1.25 | 1.25 | 22.37 | 15.82 | 0.5312 | 4.22 | 1.84 | 2,304,219.00 | 6.21 | 6.57 | 12.82 | 13.26 | 52.48 | 59.89 | 11.70 | 12.62 | 1.73 | -- | 0.1919 | 28.27 | 7.82 | 15.35 | -5.43 | 2.88 | 3.63 | 2.92 |
| CARsgen Therapeutics Holdings Ltd | 0.00 | -806.36m | 3.70bn | 516.00 | -- | 1.91 | -- | -- | -1.45 | -1.45 | 0.00 | 3.38 | 0.00 | -- | -- | 0.00 | -29.79 | -- | -32.14 | -- | -- | -- | -- | -- | 9.54 | -- | 0.0452 | -- | -- | -- | 16.19 | -- | -- | -- |
| Biocytogen Pharmaceuticals Beijng Co Ltd | 773.06m | -412.94m | 3.89bn | 1.07k | -- | 4.59 | -- | 5.03 | -1.04 | -1.04 | 1.94 | 2.12 | 0.2732 | 16.21 | 5.74 | 725,193.00 | -14.59 | -- | -18.88 | -- | 70.59 | -- | -53.42 | -- | 1.24 | -21.30 | 0.4077 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
| CK Life Sciences Intl (Holdings) Inc | 5.32bn | 17.25m | 3.99bn | 1.93k | 231.84 | 0.9521 | 35.18 | 0.7494 | 0.0018 | 0.0018 | 0.5538 | 0.4359 | 0.4728 | 2.96 | 4.74 | 2,755,038.00 | 0.1532 | 1.11 | 0.211 | 1.43 | 30.76 | 30.52 | 0.3241 | 2.42 | 0.8512 | 0.8796 | 0.5861 | 59.00 | 0.8936 | 0.3407 | -86.93 | -42.01 | 0.2784 | -- |
| Jiangsu Recbio Technology Co Ltd | 0.00 | -616.75m | 4.42bn | 472.00 | -- | 3.79 | -- | -- | -1.28 | -1.28 | 0.00 | 2.41 | 0.00 | -- | -- | 0.00 | -25.47 | -- | -30.68 | -- | -- | -- | -- | -- | 2.33 | -- | 0.378 | -- | -- | -- | 20.86 | -- | -- | -- |
| Alphamab Oncology | 235.91m | -227.09m | 4.73bn | 435.00 | -- | 2.62 | -- | 20.04 | -0.2362 | -0.2362 | 0.2458 | 1.87 | 0.1028 | 0.7705 | 19.34 | 542,314.80 | -9.90 | -18.72 | -11.69 | -21.94 | 74.75 | -- | -96.26 | -415.55 | 5.55 | -- | 0.1333 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
| Ocumension Therapeutics | 265.66m | -409.53m | 4.76bn | 444.00 | -- | 1.50 | -- | 17.94 | -0.6311 | -0.6311 | 0.4092 | 4.56 | 0.078 | 3.61 | 2.12 | 598,335.10 | -12.03 | -38.78 | -13.21 | -41.47 | 58.60 | 62.30 | -154.16 | -975.82 | 3.72 | -- | 0.0451 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
| Shandong Boan Biotechnology Co Ltd | 666.54m | -128.73m | 4.90bn | 813.00 | -- | 3.45 | -- | 7.36 | -0.2528 | -0.2528 | 1.31 | 2.79 | 0.2732 | 1.35 | 2.53 | 819,848.30 | -5.28 | -- | -7.02 | -- | 66.16 | -- | -19.31 | -- | 0.8383 | -7.47 | 0.2491 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -268.88m | 4.96bn | 133.00 | -- | 4.51 | -- | -- | -1.34 | -1.34 | 0.00 | 5.44 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 6.41 | -- | 0.0185 | -- | -- | -- | 65.62 | -- | -- | -- |
| Microport NeuroTech Ltd | -100.00bn | -100.00bn | 5.24bn | 571.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 21.61 | -- | 768.73 | -- | -- | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | -100.00bn | -100.00bn | 5.41bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -28.25 | -- | 5.82 | -- | -- | -- |
Data as of May 23 2024. Currency figures normalised to CK Life Sciences Intl (Holdings) Inc's reporting currency: Hong Kong Dollar HKD
1.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 09 May 2024 | 35.04m | 0.37% |
| Dimensional Fund Advisors LPas of 09 May 2024 | 28.51m | 0.30% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 22.48m | 0.23% |
| TIAA-CREF Investment Management LLCas of 31 Mar 2024 | 2.59m | 0.03% |
| Legal & General Investment Management Ltd.as of 28 Mar 2024 | 1.90m | 0.02% |
| Mercer Global Investments Europe Ltd.as of 30 Jun 2023 | 1.53m | 0.02% |
| Credit Suisse Asset Management (Schweiz) AGas of 29 Feb 2024 | 1.33m | 0.01% |
| The Vanguard Group, Inc.as of 30 Apr 2024 | 1.21m | 0.01% |
| DFA Australia Ltd.as of 31 Mar 2024 | 887.79k | 0.01% |
| Geode Capital Management LLCas of 29 Feb 2024 | 800.00k | 0.01% |
More ▼
Data from 31 Dec 2023 - 16 May 2024Source: FactSet Research Systems Inc.
